LQDA Q2 2022 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+16.1% YoY

Gross Profit

$3M81.3% margin

Operating Income

-$9M-228.9% margin

Net Income

-$9M-241.1% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+12.2%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$139M

Total Liabilities

$37M

Stockholders' Equity

$102M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+16.1%
Gross Profit	$3M	$3M	+19.7%
Operating Income	-$9M	-$6M	-41.2%
Net Income	-$9M	-$7M	-44.2%